Cargando…
Next-Generation TB Vaccines: Progress, Challenges, and Prospects
Tuberculosis (TB), caused by Mycobacterium tuberculosis (MTB), is a prevalent global infectious disease and a leading cause of mortality worldwide. Currently, the only available vaccine for TB prevention is Bacillus Calmette–Guérin (BCG). However, BCG demonstrates limited efficacy, particularly in a...
Autores principales: | Zhuang, Li, Ye, Zhaoyang, Li, Linsheng, Yang, Ling, Gong, Wenping |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10457792/ https://www.ncbi.nlm.nih.gov/pubmed/37631874 http://dx.doi.org/10.3390/vaccines11081304 |
Ejemplares similares
-
Immunotherapy and biomarkers in patients with lung cancer with tuberculosis: Recent advances and future Directions
por: Yang, Ling, et al.
Publicado: (2023) -
Progress and challenges in TB vaccine development
por: Voss, Gerald, et al.
Publicado: (2018) -
Next-generation influenza vaccines: opportunities and challenges
por: Wei, Chih-Jen, et al.
Publicado: (2020) -
Prospects of Next-Generation Vaccines for Bluetongue
por: van Rijn, Piet A.
Publicado: (2019) -
Intervention of next-generation sequencing in diagnosis of Alzheimer’s disease: challenges and future prospects
por: Chandy, Tijimol
Publicado: (2023)